Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Zhejiang Cancer Hospital
Kind Pharmaceuticals LLC
Kind Pharmaceuticals LLC
M.D. Anderson Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Boston Children's Hospital
Masonic Cancer Center, University of Minnesota
Beth Israel Deaconess Medical Center
Centre Henri Becquerel
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Affiliated Hospital of Nantong University
H. Lee Moffitt Cancer Center and Research Institute
Children's Hospital of Philadelphia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
University Hospital Tuebingen
Henan Cancer Hospital
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
New York Medical College
Masonic Cancer Center, University of Minnesota
Beijing Suncadia Pharmaceuticals Co., Ltd
Indiana University
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
The University of Hong Kong
City of Hope Medical Center
Children's Hospital Medical Center, Cincinnati
City of Hope Medical Center
Thomas Jefferson University
Anhui Provincial Hospital
Istituto Clinico Humanitas
Fred Hutchinson Cancer Center